Delta tocotrienol in recurrent ovarian cancer. A phase II trial

Overview of attention for article published in Pharmacological Research, January 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#40 of 3,584)
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

So far, Altmetric has seen 23 news stories from 13 outlets.

Designs for Health commend this groundbreaking study from Denmark, which advances women's health and offers hope for women…

SOURCE Designs for Health Designs for Health commend this groundbreaking study from Denmark, which advances women's health and…

SOURCE Designs for Health Designs for Health commend this groundbreaking study from Denmark, which advances women's health and…

SOURCE Designs for Health Designs for Health commend this groundbreaking study from Denmark, which advances women's health and…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 19 additional news stories.